Validation of a Proprietary Deterioration Index Model and Performance in Hospitalized Adults.
Journal
JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235
Informations de publication
Date de publication:
03 07 2023
03 07 2023
Historique:
medline:
25
7
2023
pubmed:
24
7
2023
entrez:
24
7
2023
Statut:
epublish
Résumé
The Deterioration Index (DTI), used by hospitals for predicting patient deterioration, has not been extensively validated externally, raising concerns about performance and equitable predictions. To locally validate DTI performance and assess its potential for bias in predicting patient clinical deterioration. This retrospective prognostic study included 13 737 patients admitted to 8 heterogenous Midwestern US hospitals varying in size and type, including academic, community, urban, and rural hospitals. Patients were 18 years or older and admitted between January 1 and May 31, 2021. DTI predictions made every 15 minutes. Deterioration, defined as the occurrence of any of the following while hospitalized: mechanical ventilation, intensive care unit transfer, or death. Performance of the DTI was evaluated using area under the receiver operating characteristic curve (AUROC) and area under the precision recall curve (AUPRC). Bias measures were calculated across demographic subgroups. A total of 5 143 513 DTI predictions were made for 13 737 patients across 14 834 hospitalizations. Among 13 918 encounters, the mean (SD) age of patients was 60.3 (19.2) years; 7636 (54.9%) were female, 11 345 (81.5%) were White, and 12 392 (89.0%) were of other ethnicity than Hispanic or Latino. The prevalence of deterioration was 10.3% (n = 1436). The DTI produced AUROCs of 0.759 (95% CI, 0.756-0.762) at the observation level and 0.685 (95% CI, 0.671-0.700) at the encounter level. Corresponding AUPRCs were 0.039 (95% CI, 0.037-0.040) at the observation level and 0.248 (95% CI, 0.227-0.273) at the encounter level. Bias measures varied across demographic subgroups and were 14.0% worse for patients identifying as American Indian or Alaska Native and 19.0% worse for those who chose not to disclose their ethnicity. In this prognostic study, the DTI had modest ability to predict patient deterioration, with varying degrees of performance at the observation and encounter levels and across different demographic groups. Disparate performance across subgroups suggests the need for more transparency in model training data and reinforces the need to locally validate externally developed prediction models.
Identifiants
pubmed: 37486632
pii: 2807550
doi: 10.1001/jamanetworkopen.2023.24176
pmc: PMC10366696
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2324176Subventions
Organisme : NCATS NIH HHS
ID : UL1 TR002494
Pays : United States
Références
J Med Internet Res. 2021 Feb 4;23(2):e25187
pubmed: 33538696
JAMA Netw Open. 2021 Oct 1;4(10):e2130479
pubmed: 34673962
J Hosp Med. 2019 Mar;14(3):161-169
pubmed: 30811322
Nat Med. 2022 Jun;28(6):1159-1160
pubmed: 35710994
Crit Care Explor. 2023 May 01;5(5):e0897
pubmed: 37151895
Crit Care Med. 2019 Jan;47(1):49-55
pubmed: 30247239
Crit Care Med. 2022 May 1;50(5):799-809
pubmed: 34974496
BMC Med. 2019 Dec 16;17(1):230
pubmed: 31842878
JAMA Netw Open. 2022 Aug 1;5(8):e2227779
pubmed: 35984654
J Biomed Inform. 2020 May;105:103410
pubmed: 32278089
Crit Care Med. 2023 Jun 1;51(6):775-786
pubmed: 36927631
Science. 2019 Oct 25;366(6464):447-453
pubmed: 31649194
Ann Am Thorac Soc. 2021 Jul;18(7):1129-1137
pubmed: 33357088
IEEE J Biomed Health Inform. 2022 Nov;26(11):5728-5737
pubmed: 36006882
PLoS One. 2022 Jan 5;17(1):e0262193
pubmed: 34986168
J Biomed Inform. 2016 Dec;64:10-19
pubmed: 27658885
Sci Rep. 2022 Mar 10;12(1):4209
pubmed: 35273279
J Adv Nurs. 2017 Dec;73(12):2877-2891
pubmed: 28727184
JMIR Med Inform. 2021 Apr 21;9(4):e25066
pubmed: 33818393
N Engl J Med. 2020 Nov 12;383(20):1951-1960
pubmed: 33176085
J Patient Saf. 2022 Jan 1;18(1):e140-e155
pubmed: 32453105
JAMA Intern Med. 2021 Aug 1;181(8):1065-1070
pubmed: 34152373